Multiple Myeloma

MD IQ

News

Better PFS may not mean better HRQOL

Cancer treatments that prolong progression-free survival (PFS) may not improve health-related quality of life (HRQOL), researchers reported in...

News

Questions surround MRD assessment in MM

DUBROVNIK, CROATIA—Clinical trials are needed to answer the many questions related to minimal residual disease (MRD) assessment in multiple...

Pages